MetLife Stock Rating Reaffirmed by TheStreet (MET)
MetLife (NYSE:MET)‘s stock had its “buy” rating reaffirmed by equities research analysts at TheStreet in a research note issued to investors on Tuesday, Analyst Ratings Network reports.
The analysts wrote, “MetLife (MET) has been reiterated by TheStreet Ratings as a buy with a ratings score of B. The company’s strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, impressive record of earnings per share growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins.”
Shares of MetLife (NYSE:MET) opened at 47.86 on Tuesday. MetLife has a 52-week low of $30.55 and a 52-week high of $51.65. The stock has a 50-day moving average of $48.08 and a 200-day moving average of $46.20. The company has a market cap of $52.339 billion and a price-to-earnings ratio of 21.38.
MetLife (NYSE:MET) last issued its quarterly earnings data on Thursday, October 31st. The company reported $1.34 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.34. The company had revenue of $16.90 billion for the quarter, compared to the consensus estimate of $17.23 billion. During the same quarter last year, the company posted $1.32 earnings per share. MetLife’s revenue was up 1.7% compared to the same quarter last year. Analysts expect that MetLife will post $5.63 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, December 13th. Investors of record on Friday, November 8th will be paid a dividend of $0.28 per share. This represents a $1.10 annualized dividend and a dividend yield of 2.29%. The ex-dividend date is Wednesday, November 6th.
Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of MetLife in a research note to investors on Friday. They now have a $50.00 price target on the stock. Separately, analysts at Keefe, Bruyette & Woods raised their price target on shares of MetLife from $54.00 to $57.00 in a research note to investors on Monday, October 21st. They now have an “outperform” rating on the stock. Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $53.11.
MetLife, Inc (NYSE:MET), is a provider of insurance, annuities and employee benefit programs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.